Page results
-
UCLH Charity’s magazine, Charity Matters is out now.
-
UCLH doctor 1 of 10 international members elected to National Academy of Medicine
-
The designs of a new breathing aid developed by engineers at UCL and Formula One working with clinicians at UCLH have been made freely available to support the global response to Covid-19.
-
Following funding approval by NHS England, the Royal National Orthopaedic Hospital Trust (RNOH) will work with UCLH to implement an extension of our Epic Electronic Health Record (EHR).
-
Information about the elected council of governors for UCLH - patient governors
-
A BBC film which looks at the work of scientists at UCL and clinicians at UCLH working together on groundbreaking ‘first in-human’ immunotherapy trials is being shown again on BBC2 tonight.
-
A study at UCLH has found a combination treatment of immunotherapy with an experimental drug may reverse a cancer’s resistance to immunotherapy – making the cancer sensitive to treatment again.
-
The UCLH and Great Ormond Street Hospital paediatric neuro-oncology service, which treats children with brain cancer, has been designated as one of six new ‘Tessa Jowell Centres of Excellence’.
-
Professor Beate Diehl is a consultant neurologist, clinical neurophysiologist and clinical senior lecturer.
File results
-
FOI/2022/0717 - Digital Healthcare organisation chart
-
FOI/2022/0718 - Clinical service incidents caused by estates and infrastructure in 2021/22
-
FOI/2022/0722 - Procedures for patients on lateral flow tests and wearing masks in hospital
-
FOI/2022/0723 - Spend on external companies for intraoperative neuromonitoring (IONM)
-
FOI/2022/0724 - Radiology enquiry - brain imaging, prostate, breast, Liver, Gynaecological scans within MRI
-
FOI/2022/0725 - High Acuity Monitoring - NCIU, Theatres, ICU
-
FOI/2022/0728 - Digital/ data team structures
-
FOI/2022/0730 - Outpatient unit day procedures for haematology patients
-
FOI/2022/0734 - A&E attendances for episodes of sunburn and/ or effects of heat and light
-
FOI/2022/0739 - Treatment of HR+ adjuvant breast cancer